Taking Benicar? Beware Of Potentially Deadly Side Effects

For people at risk of strokes and other medical conditions involving blood clots, the only medication available for decades was a pill called warfarin, which was notorious for its risk of serious and potentially deadly side effects.

Benicar: Another Popular Drug With A Risk Of Serious Complications

Drug Benicar, or olmesartan medoxomil, which is used to treat patients with high blood pressure. In some patients, however, the drug can cause severe gastrointestinal problems that may result in long-term complications if left untreated.

The gastrointestinal side effects of Benicar — which may include severe diarrhea, dehydration and weight changes — can closely mimic those caused by celiac disease, an autoimmune disorder that causes the body to have trouble digesting certain proteins known as glutens. As a result, patients suffering negative effects from Benicar may be misdiagnosed as gluten intolerant and continue taking the harmful medication, thus prolonging their suffering and causing additional harm.

Eventually, however, it may be discovered that the patient is not actually suffering from Celiac disease at all, but instead that he or she has a condition known as sprue-like enteropathy, which has been linked to Benicar. Along with malnutrition, dramatic weight loss, chronic diarrhea and stomach pain, other symptoms include:

  • Swelling
  • Chest pain
  • Liver and kidney problems
  • Rash
  • Irregular heartbeat
  • Nausea and vomiting
  • Arthritis
  • Hair loss

The risk of serious complications associated with Benicar are no secret within the medical community. Before prescribing such powerful and potentially dangerous drugs, doctors have a responsibility to make sure it will not pose an undue risk to the patient's health and safety, and to warn patients of any risks they could face by using the drug. Patients who have been harmed by either drug are encouraged to speak with a medical malpractice lawyer to learn about their rights and legal options.